Arteaga, Daniel F. http://orcid.org/0000-0002-6690-135X
Ulep, Robin
Kumar, Kevin K.
Southerland, Andrew M.
Conaway, Mark R.
Faber, James
Wintermark, Max
Joyner, David
Sharashidze, Vera
Hirsch, Karen
Giurgiutiu, Dan-Victor
Hannawi, Yousef
Aziz, Yasmin
Shutter, Lori
Visweswaran, Anita
Williams, Alana
Williams, Kori
Gunter, Sonya
Haughey, Heather M.
Bruno, Askiel
Johnston, Karen C.
Patel, Vishal N.
,
Funding for this research was provided by:
National Institutes of Health (NIH-NINDS U01 NS069498, NIH-NINDS U01 NS056975, NIH-NINDS U01 NS059041)
Article History
Received: 4 January 2022
Accepted: 27 October 2022
First Online: 4 November 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the Center for Health Humanities and Ethics committee at the University of Virginia, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The protocol for the original SHINE trial was approved by the institutional review board at each participating site, and all patients were enrolled after providing written informed consent.
: Not applicable.
: AMS discloses research support from the American Heart Association, Diffusion Pharmaceuticals, Inc. and Abbvie, Inc. He also performs paid expert consultation in medical legal review of stroke related cases.